Abstract:Expressive molecular representation plays critical roles in researching drug design, while effective methods are beneficial to learning molecular representations and solving related problems in drug discovery, especially for drug-drug interactions (DDIs) prediction. Recently, a lot of work has been put forward using graph neural networks (GNNs) to forecast DDIs and learn molecular representations. However, under the current GNNs structure, the majority of approaches learn drug molecular representation from one-dimensional string or two-dimensional molecular graph structure, while the interaction information between chemical substructure remains rarely explored, and it is neglected to identify key substructures that contribute significantly to the DDIs prediction. Therefore, we proposed a dual graph neural network named DGNN-DDI to learn drug molecular features by using molecular structure and interactions. Specifically, we first designed a directed message passing neural network with substructure attention mechanism (SA-DMPNN) to adaptively extract substructures. Second, in order to improve the final features, we separated the drug-drug interactions into pairwise interactions between each drug's unique substructures. Then, the features are adopted to predict interaction probability of a DDI tuple. We evaluated DGNN–DDI on real-world dataset. Compared to state-of-the-art methods, the model improved DDIs prediction performance. We also conducted case study on existing drugs aiming to predict drug combinations that may be effective for the novel coronavirus disease 2019 (COVID-19). Moreover, the visual interpretation results proved that the DGNN-DDI was sensitive to the structure information of drugs and able to detect the key substructures for DDIs. These advantages demonstrated that the proposed method enhanced the performance and interpretation capability of DDI prediction modeling. Drug-drug interactions (DDIs) may cause adverse effects that damage the body. Therefore, it is critical to predict potential drug-drug interactions. The majority of the prediction techniques still rely on the similarity hypothesis for drugs, sometimes neglect the molecular structure, and fail to include the interaction information between chemical substructure when predicting DDIs. We exploited this idea to develop and confirm the role that molecular structure and interaction information between chemical substructure play in DDIs prediction. The model includes a molecular substructure extraction framework to explain why substructures contribute differently to DDIs prediction, and a co-attention mechanism to explain why the interaction information between chemical substructure can improve DDIs prediction. Compared to state-of-the-art methods, the model improved the performance of DDIs prediction on real-world dataset. Furthermore, it could identify crucial components of treatment combinations that might be efficient against the emerging coronavirus disease 2019 (COVID-19).

BiRNN-DDI: A Drug-Drug Interaction Event Type Prediction Model Based on Bidirectional Recurrent Neural Network and Graph2Seq Representation

Multi-Relational Contrastive Learning Graph Neural Network for Drug-Drug Interaction Event Prediction

Drug-drug Interaction Prediction with Graph Representation Learning

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

Bi-Level Graph Neural Networks for Drug-Drug Interaction Prediction

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

DSN-DDI: an accurate and generalized framework for drug–drug interaction prediction by dual-view representation learning

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

Enhancing drug–drug interaction prediction by three-way decision and knowledge graph embedding

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

AutoDDI: Drug–Drug Interaction Prediction With Automated Graph Neural Network

A dual graph neural network for drug–drug interactions prediction based on molecular structure and interactions

Predicting drug–drug interactions by graph convolutional network with multi-kernel

STNN-DDI: A Substructure-aware Tensor Neural Network to Predict Drug-Drug Interactions

Graph-augmented Convolutional Networks on Drug-Drug Interactions Prediction

Drug-drug Interaction Extraction via Recurrent Neural Network with Multiple Attention Layers

SubGE-DDI: A new prediction model for drug-drug interaction established through biomedical texts and drug-pairs knowledge subgraph enhancement

GCN-BMP: Investigating graph representation learning for DDI prediction task

Benchmarking Graph Learning for Drug-Drug Interaction Prediction